All News and Events

25 March 2026

Event jointly organized by: AVE and St Vincent's Institute of Medical Research

6 January 2026

Please join us for a special Fireside chat on January 6th, 2026

21 May 2025

Event jointly organized by : Institute for Bioengineering of Catalunya (IBEC) and Centre for Genomic Regulation (CRG)

10 November 2025

We aim to strike a balance between theoretical, computational, and experimental approaches to ensure comprehensive coverage of the field.

30 October 2025

An international team led by a University of Pittsburgh School of Medicine scientist has created a first-of-its-kind resource to identify those with a genetic risk for elevated “bad” cholesterol—a major contributor to heart disease. Published in Science on Oct. 30, 2025, this resource can assist clinicians in predicting patient risk for heart attacks, allowing time for prevention and early treatment. 

30 October 2025

An international team led by a University of Pittsburgh School of Medicine scientist has created a first-of-its-kind resource to identify those with a genetic risk for elevated ‘bad’ cholesterol -- a major contributor to heart disease. 

17 December 2025

How can we use genomic technologies to tackle blood diseases? In this episode, we explain the role of genetic variants in blood disorders and how genomics approaches, such as gene editing can help cure these diseases.

30 June 2025

Who do you ask if you have a question about a gene? In this episode, we dive into the teams and scientists that are building an encyclopedia of knowledge about your genes.

Transcript and show notes can be found here.

23 March 2025

We can predict the weather, but can we predict genetic diseases from your genome?

In this episode we explain the challenges and the promises of variant effect predictors (VEPs)

with experts Dr Debbie Marks and Dr Joe Marsh

2 December 2025

Taylor grew up in Illinois on the banks of the Mississippi River. He did the PhD in Brian O’Roak’s lab in Portland, Oregon, where he studied mutational effects on the cancer and autism risk gene, PTEN. For postdoctoral work, he moved to Ben Lehner’s lab in Barcelona, where he has focussed on developing and deploying massive mutagenesis platforms for understanding expression and function of GPCRs, the most important family of drug targets.

6 January 2026

The Dunham lab develops and applies genomic tools to study genome evolution and genetic variation in yeast and humans.  We utilize the budding yeasts as a testbed for technology development and as an experimentally tractable system for evolutionary genetics and genomics.

6 January 2026

Matthew Hurles is Director of the Wellcome Sanger Institute and leads a research group focused on deciphering the genetic causes of severe developmental disorders, and understanding how DNA mutates as it is passed from generation to generation.